CALIXAR helps pharmaceutical and biotechnological companies as well as academic life sciences organizations to preserve and resolve the original structure of proteins during target discovery stage.
CALIXAR provides a range of services based on innovative technologies for production, extraction, solubilization, purification, stabilization and crystallization of functional membrane proteins / antigens.
We improve the reliability of targets for a better performance of high throughput screening and structure-based drug design approaches, the production of vaccines, biodrugs and for the development of diagnostic tools.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 06/01/12 | Other | 1.1M | Unknown |